Onbevzi

bevacizumab · Samsung Bioepis NL B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Onbevzi, covering 2024-10-24 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma [Phase 2]